Atreca Inc (FRA:0C1)
€ 0.0435 -0.0715 (-62.17%) Market Cap: 2.93 Mil Enterprise Value: -15.66 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 0/100

Q4 2022 Atreca Inc Earnings Call Transcript

Mar 29, 2023 / 08:30PM GMT
Release Date Price: €1.18 (+9.26%)
Operator

Thank you for standing by, and welcome to Atreca's fourth-quarter and year-end 2022 earnings call. (Operator Instructions)

I would now like to hand the call over to Head of Investor Relations, Alex Gray. Please go ahead.

Alex Gray
Atreca, Inc. - Associate Director, Corporate Communications

Thank you, operator, and thank you to those joining us today. We are pleased to host our year-end 2022 conference call and webcast, including updated data from our ongoing Phase 1b trial of ATRC-101. Joining me for the prepared remarks are John Orwin, CEO; Dr. Tito Serafini, Chief Strategy Officer and Atreca Founder; Dr. Philippe Bishop, Chief Medical Officer; and Dr. Stephen Gould, Chief Scientific Officer. Also on the line is Herb Cross, Chief Financial Officer, who will be available during the Q&A session.

For those joining by phone, I'd note that we are presenting slides as part of today's program, which can be viewed via the webcast link included in our earnings release and posted to the Events and Presentations section of our Investor Relations

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot